Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 28.39%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
28.39%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 386 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Black Diamond Therapeutics, Inc.
Market Cap
$111.17M
Operating Margin
28.39%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$109.49M
Operating Margin
-6.06%
TTM Avg
-25.69%
3Y Avg
-34.32%
5Y Avg
-39.92%
Market Cap
$113.77M
Operating Margin
-255.05%
TTM Avg
-370.20%
3Y Avg
-218.02%
5Y Avg
-145.34%
Market Cap
$108.39M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1578.22%
Market Cap
$114.24M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$106.23M
Operating Margin
-6.27%
TTM Avg
-11.63%
3Y Avg
-15.25%
5Y Avg
-16.56%
Market Cap
$117.43M
Operating Margin
-265.64%
TTM Avg
-359.98%
3Y Avg
-411.27%
5Y Avg
-4203.28%
Market Cap
$118.02M
Operating Margin
-1220.49%
TTM Avg
-1443.83%
3Y Avg
-998.11%
5Y Avg
-830.42%
Market Cap
$104.07M
Operating Margin
-8.52%
TTM Avg
-145.19%
3Y Avg
-110.33%
5Y Avg
-78.53%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | $111.17M | 28.39% | 0.00% | 0.00% | 0.00% |
| Apyx Medical Corporation (APYX)vs › | $109.49M | -6.06% | -25.69% | -34.32% | -39.92% |
| Coya Therapeutics, Inc. (COYA)vs › | $113.77M | -255.05% | -370.20% | -218.02% | -145.34% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.39M | 0.00% | 0.00% | 0.00% | -1578.22% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $114.24M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.23M | -6.27% | -11.63% | -15.25% | -16.56% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $117.43M | -265.64% | -359.98% | -411.27% | -4203.28% |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.02M | -1220.49% | -1443.83% | -998.11% | -830.42% |
| Definitive Healthcare Corp. (DH)vs › | $104.07M | -8.52% | -145.19% | -110.33% | -78.53% |
| BGM Group Ltd. (BGM)vs › | $118.63M | -33.18% | -17.71% | -9.45% | -4.00% |
Gross Margin
99.5%
Operating Margin
28.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 77.90% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
